CompletedNot Applicable

ELECTROVEST: Electro-Stimulation Vibratory Vest for Pulmonary Rehabilitation in Patients With Chronic Respiratory Diseases

Spain21 participantsStarted 2023-10-02

Plain-language summary

This study will evaluate the effectiveness, safety, and tolerability of a novel wearable device, the ELECTROVEST, designed to improve airway clearance in patients with chronic respiratory diseases. The ELECTROVEST will integrate high-frequency chest wall oscillation (HFCWO) with surface neuromuscular electrostimulation. This crossover clinical trial will compare the performance of the ELECTROVEST with a standard HFCWO vest (The Vest®) in adult patients. Primary outcomes will include sputum expectoration and patient-reported comfort. The study will aim to determine whether this new system can optimize bronchial hygiene.

Who can participate

Age range16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with Chronic Respiratory Diseases Diagnosed with chronic respiratory disease with bronchial hypersecretion: COPD, cystic fibrosis, bronchiectasis, or asthma * Age \>16 years * Clinically stable (no exacerbations in past 4 weeks) Exclusion Criteria: * Risk of pneumothorax and/or barotrauma * Risk or history of hemoptysis * On active waiting list for lung transplant or surgery * Musculoskeletal or other limiting condition * Diagnosis of osteoporosis

What they're measuring

Volume of Expectorated Sputum

Timeframe: Immediately post-intervention (within 1 hour)

Discomfort Level (VAS Score)

Timeframe: Immediately after each intervention session

Trial details

NCT IDNCT07175012

SponsorHospitales Universitarios Virgen del Rocío

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-07

View on ClinicalTrials.gov More COPD (Chronic Obstructive Pulmonary Disease) trials